The program celebrates creative excellence in the highly specialized fields of health and wellness.
Google introduced a number of new features as part of the Google Marketing Live 2022 event. As data privacy becomes more and more important, Google has introduced measures to ensure conversion tracking and attribution can be accurately measured without compromising user data. In addition, they have expanded some ad offerings as well, according to Christa Toole, Partner, Search and Analytics, at Greater Than One.
The U.S. Supreme Court on Wednesday ruled in favor of a group of nonprofit hospitals in their bid to restore billions of dollars cut by the government from their annual Medicare reimbursements since 2018.
Achieving genuine human connection is a crucial part of survival. We all want to feel seen and heard, whether it’s on a casual level during a conversation about work, or on a humorous level exchanging the adventures of parenting, or at the very deep level of discussing and sharing mental health challenges. When it comes down to it, we want to be understood and supported, not necessarily by everyone we know but by the people who matter to us most. We want – we need – empathy. And when it comes to health, and managing the healthcare journey, this concept is no different.
The long-awaited digital transformation of life sciences has arrived. It went from a promise to a need.
Med Ad News sits down with Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories. He has more than 20 years of experience in the pharmaceutical industry with extensive knowledge and understanding of generics.
It is vital that, from the beginning of a medicine’s development, a regulatory strategy is built into all activities so companies may optimize value, control costs and reduce risks – all while ensuring proper compliance. If any step is missed along the way, lifescience companies will encounter roadblocks in the form of delays on approval cycles and lack of proper data control, which can impact the long-term revenue for the medicine.
In December 2021, the FDA issued draft guidance to lifescience researchers on evaluating EHR and claims data in studies to support regulatory decisions. This new draft guidance covers using real-world data from these sources to support regulatory decisions on both safety and effectiveness.
Few industries affect consumers on a more personal level than the healthcare industry. Pharma companies, in particular, have a unique challenge in making more meaningful customer connections.
Thanks to the meteoric rise of digital health, the role of data and analytics has also become central across the drug development life cycle, impacting every touch point from pipeline research and development to clinical trial design and implementation. A critical area that has fallen short, however, is applying a commensurate level of enthusiasm and expense for market research in the early phase as that afforded to downstream commercialization efforts. Compounding this challenge is the continued marginalization of disenfranchised communities.
